Four Off-Label Medications for Long Covid to be Reimbursed by Health Insurers

In Germany, a decision has been made to reimburse four medications for Long Covid and Post-Covid by health insurance companies, despite them being approved for other indications, as there are currently no approved drugs specifically for these conditions.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman63d ago

Off-Label: Vier Medikamente gegen Long Covid

Bislang gibt es keine zugelassenen Arzneien gegen Long Covid und Post-Covid. Nun wurde aber entschieden, dass vier Medikamente von den Krankenkassen erstattet werden, die eigentlich für andere Indikationen zugelassen sind.

Read full article →

PERSPECTA

PERSPECTA

Four Off-Label Medications for Long Covid to be Reimbursed by Health Insurers

Sources

Off-Label: Vier Medikamente gegen Long Covid

Related Stories

Extreme Training: What Heat Training Does to the Body

Experts Explain Optimal Summer Indoor Temperature and AC Use for Sleep

Vitamin Supporting Brain Health and Reducing Cognitive Decline Risk Identified

Rural Health Centers in Adamawa, Nigeria, Rely on Volunteers Amid Staffing Shortages

PERSPECTA